76:
49:
376:
138:
and plaque-like skin eruption which can occur on the neck, face and back and may re-occur. This is an uncommon skin disease and is a benign collection of lymph cells. Its cause is not known and can be hereditary. It is named for
1326:
41:
Borrelial lymphocytoma, lymphadenosis benigna cutis, lymphocytoma cutis, pseudolymphoma, pseudolymphoma of
Spiegler and Fendt, sarcoidosis of Spiegler and Fendt, SpieglerâFendt lymphoid hyperplasia, SpieglerâFendt
1070:
624:
741:
1331:
1140:
1354:
706:
1395:
1096:
435:
786:
1299:
1338:
884:
629:
763:
864:
662:
1288:
962:
516:
1135:
104:
Cutaneous lymphoid hyperplasia with nodular pattern, a condition of the skin characterized by a solitary or localized cluster of asymptomatic
954:
505:
219:
1283:
1239:
859:
657:
541:
1130:
341:
428:
253:
1091:
1172:
1050:
989:
975:
869:
810:
647:
573:
1369:
1279:
1229:
1125:
854:
638:
1261:
1167:
1150:
958:
512:
421:
1202:
1075:
781:
144:
1117:
1005:
846:
768:
115:
Cutaneous lymphoid hyperplasia with bandlike and perivascular patterns, a condition of the skin characterized by
1207:
1035:
396:
673:
1224:
775:
1101:
1080:
994:
1233:
823:
717:
796:
619:
1030:
642:
553:
75:
830:
614:
584:
1294:
159:
155:
17:
331:
1374:
1044:
1025:
1014:
804:
694:
609:
337:
295:
249:
215:
120:
64:
1144:
923:
791:
690:
413:
917:
912:
721:
605:
471:
466:
313:
274:
1364:
151:
97:
48:
1389:
1271:
970:
879:
835:
652:
526:
874:
536:
171:
105:
88:
refers to a groups of benign cutaneous disorders characterized by collections of
548:
401:
176:
140:
116:
69:
269:
444:
385:
93:
89:
318:
181:
299:
1359:
1187:
898:
461:
448:
56:
368:
907:
380:
135:
109:
730:
595:
579:
286:
ORFUSS AJ (October 1953). "Lymphocytic infiltration of the skin".
210:
Rapini, Ronald P.; Bolognia, Jean L.; Jorizzo, Joseph L. (2007).
1193:
1087:
1066:
984:
726:
701:
681:
677:
564:
482:
477:
389:
417:
933:
928:
818:
1071:
Non-mycosis fungoides CD30â cutaneous large T-cell lymphoma
244:
James, William D.; Berger, Timothy G.; et al. (2006).
134:
is a cutaneous condition characterized by a persistent
100:
in the skin. Conditions included in this groups are:
358:
1347:
1312:
1270:
1252:
1216:
1186:
1159:
1114:
1059:
1013:
1004:
944:
906:
897:
845:
755:
716:
672:
594:
563:
525:
504:
493:
460:
362:
246:
63:
37:
32:
1141:Peripheral T-cell lymphoma not otherwise specified
330:Schachner, Lawrence A.; Hansen, Ronald C. (2011).
963:Precursor T acute lymphoblastic leukemia/lymphoma
517:Precursor B acute lymphoblastic leukemia/lymphoma
707:Nodular lymphocyte predominant Hodgkin lymphoma
1097:Secondary cutaneous CD30+ large-cell lymphoma
429:
239:
237:
235:
233:
231:
8:
787:Post-transplant lymphoproliferative disorder
742:immunoproliferative immunoglobulin disorders
314:Jessner Lymphocytic Infiltration of the Skin
1300:Diffuse infiltrative lymphocytosis syndrome
1339:Jessner lymphocytic infiltrate of the skin
1010:
941:
903:
885:Primary cutaneous follicle center lymphoma
630:Primary cutaneous follicle center lymphoma
501:
490:
457:
436:
422:
414:
359:
336:. Elsevier Health Sciences. p. 1022.
205:
203:
201:
199:
197:
154:and a number of medications used to treat
132:Jessner lymphocytic infiltrate of the skin
74:
47:
29:
865:Primary cutaneous marginal zone lymphoma
663:Primary cutaneous marginal zone lymphoma
1327:with bandlike and perivascular patterns
1289:Autoimmune lymphoproliferative syndrome
193:
1136:Enteropathy-associated T-cell lymphoma
1396:Lymphoid-related cutaneous conditions
7:
1284:X-linked lymphoproliferative disease
143:. It is thought to be equivalent to
1240:Large granular lymphocytic leukemia
860:Intravascular large B-cell lymphoma
25:
18:Lymphocytic infiltrate of Jessner
1092:CD30+ cutaneous T-cell lymphoma
1322:Cutaneous lymphoid hyperplasia
1314:Cutaneous lymphoid hyperplasia
1173:Adult T-cell leukemia/lymphoma
1051:Adult T-cell leukemia/lymphoma
990:Anaplastic large-cell lymphoma
870:Primary cutaneous immunocytoma
811:Splenic marginal zone lymphoma
150:It can occur as the result of
127:Jessner lymphocytic infiltrate
86:Cutaneous lymphoid hyperplasia
33:Cutaneous lymphoid hyperplasia
1:
1370:Lymphoproliferative disorders
1280:Lymphoproliferative disorders
1230:Extranodal NK-T-cell lymphoma
1102:Lymphomatoid papulosis type A
1081:Lymphomatoid papulosis type B
995:Lymphomatoid papulosis type A
855:Diffuse large B-cell lymphoma
1262:Acute biphenotypic leukaemia
1151:Subcutaneous T-cell lymphoma
1203:Aggressive NK-cell leukemia
1076:Pleomorphic T-cell lymphoma
782:Lymphomatoid granulomatosis
145:lupus erythematosus tumidus
1412:
456:
212:Dermatology: 2-Volume Set
119:that clinically resemble
59:lymphocytoma on the cheek
55:
46:
1355:Hematological malignancy
1208:Blastic NK cell lymphoma
1036:Granulomatous slack skin
792:Classic Hodgkin lymphoma
691:Classic Hodgkin lymphoma
288:AMA Arch Derm Syphilol
1234:Angiocentric lymphoma
824:AIDS-related lymphoma
648:Splenic marginal zone
333:Pediatric Dermatology
248:. Saunders Elsevier.
1332:with nodular pattern
1031:Pagetoid reticulosis
643:marginal zone B-cell
214:. St. Louis: Mosby.
831:Helicobacter pylori
658:Nodal marginal zone
585:Hairy cell leukemia
451:and related disease
1375:Lymphoid leukemias
1295:Leukemoid reaction
1131:Angioimmunoblastic
797:Burkitt's lymphoma
160:glatiramer acetate
156:multiple sclerosis
1383:
1382:
1308:
1307:
1248:
1247:
1182:
1181:
1110:
1109:
1026:Mycosis fungoides
893:
892:
751:
750:
695:Nodular sclerosis
610:follicular B cell
411:
410:
221:978-1-4160-2999-1
121:mycosis fungoides
83:
82:
27:Medical condition
16:(Redirected from
1403:
1145:Lennert lymphoma
1011:
942:
904:
769:Primary effusion
502:
491:
458:
438:
431:
424:
415:
360:
348:
347:
327:
321:
310:
304:
303:
283:
277:
266:
260:
259:
241:
226:
225:
207:
79:
78:
51:
30:
21:
1411:
1410:
1406:
1405:
1404:
1402:
1401:
1400:
1386:
1385:
1384:
1379:
1343:
1304:
1266:
1254:
1244:
1212:
1191:
1178:
1155:
1116:
1106:
1055:
1000:
948:
946:
921:
916:
910:
889:
841:
747:
724:
712:
668:
606:germinal center
590:
559:
521:
497:
495:
475:
470:
464:
452:
442:
412:
407:
406:
371:
357:
352:
351:
344:
329:
328:
324:
311:
307:
285:
284:
280:
267:
263:
256:
243:
242:
229:
222:
209:
208:
195:
190:
168:
129:
98:dendritic cells
73:
28:
23:
22:
15:
12:
11:
5:
1409:
1407:
1399:
1398:
1388:
1387:
1381:
1380:
1378:
1377:
1372:
1367:
1365:Leukemia cutis
1362:
1357:
1351:
1349:
1345:
1344:
1342:
1341:
1336:
1335:
1334:
1329:
1318:
1316:
1310:
1309:
1306:
1305:
1303:
1302:
1297:
1292:
1286:
1276:
1274:
1268:
1267:
1265:
1264:
1258:
1256:
1250:
1249:
1246:
1245:
1243:
1242:
1237:
1220:
1218:
1214:
1213:
1211:
1210:
1205:
1199:
1197:
1184:
1183:
1180:
1179:
1177:
1176:
1163:
1161:
1157:
1156:
1154:
1153:
1148:
1138:
1133:
1128:
1122:
1120:
1112:
1111:
1108:
1107:
1105:
1104:
1099:
1094:
1084:
1083:
1078:
1073:
1063:
1061:
1057:
1056:
1054:
1053:
1045:SĂ©zary disease
1039:
1038:
1033:
1028:
1019:
1017:
1008:
1002:
1001:
999:
998:
992:
980:
979:
976:Prolymphocytic
966:
952:
950:
939:
938:
937:
931:
901:
895:
894:
891:
890:
888:
887:
882:
877:
872:
867:
862:
857:
851:
849:
843:
842:
840:
839:
827:
815:
814:
813:
801:
800:
799:
794:
789:
784:
772:
759:
757:
753:
752:
749:
748:
746:
745:
736:
734:
714:
713:
711:
710:
698:
687:
685:
670:
669:
667:
666:
660:
655:
650:
634:
633:
627:
622:
617:
601:
599:
592:
591:
589:
588:
576:
574:Prolymphocytic
570:
568:
561:
560:
558:
557:
545:
532:
530:
523:
522:
520:
510:
508:
499:
488:
487:
486:
454:
453:
443:
441:
440:
433:
426:
418:
409:
408:
405:
404:
393:
372:
367:
366:
364:
363:Classification
356:
355:External links
353:
350:
349:
343:978-0723436652
342:
322:
305:
278:
261:
254:
227:
220:
192:
191:
189:
186:
185:
184:
179:
174:
167:
164:
152:ACE inhibitors
128:
125:
124:
123:
113:
108:to violaceous
81:
80:
67:
61:
60:
53:
52:
44:
43:
39:
35:
34:
26:
24:
14:
13:
10:
9:
6:
4:
3:
2:
1408:
1397:
1394:
1393:
1391:
1376:
1373:
1371:
1368:
1366:
1363:
1361:
1358:
1356:
1353:
1352:
1350:
1346:
1340:
1337:
1333:
1330:
1328:
1325:
1324:
1323:
1320:
1319:
1317:
1315:
1311:
1301:
1298:
1296:
1293:
1290:
1287:
1285:
1281:
1278:
1277:
1275:
1273:
1272:Lymphocytosis
1269:
1263:
1260:
1259:
1257:
1251:
1241:
1238:
1235:
1231:
1227:
1226:
1222:
1221:
1219:
1215:
1209:
1206:
1204:
1201:
1200:
1198:
1195:
1189:
1185:
1174:
1170:
1169:
1165:
1164:
1162:
1158:
1152:
1149:
1146:
1142:
1139:
1137:
1134:
1132:
1129:
1127:
1126:Hepatosplenic
1124:
1123:
1121:
1119:
1113:
1103:
1100:
1098:
1095:
1093:
1089:
1086:
1085:
1082:
1079:
1077:
1074:
1072:
1068:
1065:
1064:
1062:
1058:
1052:
1049:
1048:
1047:
1046:
1043:
1037:
1034:
1032:
1029:
1027:
1024:
1021:
1020:
1018:
1016:
1012:
1009:
1007:
1003:
996:
993:
991:
987:
986:
982:
981:
977:
973:
972:
971:prolymphocyte
968:
967:
964:
960:
956:
953:
951:
943:
940:
935:
932:
930:
927:
926:
925:
919:
914:
909:
905:
902:
900:
896:
886:
883:
881:
880:Plasmacytosis
878:
876:
873:
871:
868:
866:
863:
861:
858:
856:
853:
852:
850:
848:
844:
837:
836:MALT lymphoma
833:
832:
828:
825:
821:
820:
816:
812:
809:
808:
807:
806:
802:
798:
795:
793:
790:
788:
785:
783:
780:
779:
778:
777:
773:
770:
766:
765:
761:
760:
758:
754:
744:
743:
738:
737:
735:
732:
728:
723:
719:
715:
708:
704:
703:
699:
696:
692:
689:
688:
686:
683:
679:
675:
671:
664:
661:
659:
656:
654:
651:
649:
645:
644:
640:
639:marginal zone
636:
635:
631:
628:
626:
623:
621:
618:
616:
612:
611:
607:
603:
602:
600:
597:
593:
586:
582:
581:
577:
575:
572:
571:
569:
566:
562:
555:
551:
550:
546:
543:
539:
538:
534:
533:
531:
528:
524:
518:
514:
511:
509:
507:
503:
500:
492:
489:
484:
481:
480:
479:
473:
468:
463:
459:
455:
450:
446:
439:
434:
432:
427:
425:
420:
419:
416:
403:
399:
398:
394:
391:
387:
383:
382:
378:
374:
373:
370:
365:
361:
354:
345:
339:
335:
334:
326:
323:
320:
316:
315:
309:
306:
301:
297:
293:
289:
282:
279:
276:
275:Who Named It?
272:
271:
265:
262:
257:
255:0-7216-2921-0
251:
247:
240:
238:
236:
234:
232:
228:
223:
217:
213:
206:
204:
202:
200:
198:
194:
187:
183:
180:
178:
175:
173:
170:
169:
165:
163:
161:
157:
153:
148:
146:
142:
137:
133:
126:
122:
118:
114:
111:
107:
103:
102:
101:
99:
95:
91:
87:
77:
71:
68:
66:
62:
58:
54:
50:
45:
40:
36:
31:
19:
1321:
1313:
1223:
1166:
1160:By infection
1041:
1040:
1022:
983:
969:
947:development/
875:Plasmacytoma
829:
817:
803:
774:
762:
756:By infection
739:
700:
637:
604:
578:
547:
537:naive B cell
535:
496:development/
395:
375:
332:
325:
312:
308:
294:(4): 447â9.
291:
287:
281:
268:
264:
245:
211:
172:Lyme disease
149:
131:
130:
117:skin lesions
106:erythematous
85:
84:
1042:aggressive:
1015:MF+variants
554:Mantle cell
549:mantle zone
177:Skin lesion
141:Max Jessner
94:macrophages
90:lymphocytes
70:Dermatology
38:Other names
1118:peripheral
615:Follicular
445:Leukaemias
188:References
158:including
112:or nodules
1253:Lymphoid+
1023:indolent:
1006:Cutaneous
847:Cutaneous
625:GCB DLBCL
620:Burkitt's
449:lymphomas
319:eMedicine
270:synd/1371
182:Tick bite
65:Specialty
57:Borrelial
1390:Category
1360:leukemia
918:leukemia
913:lymphoma
472:leukemia
467:lymphoma
392:L98.812)
300:13091384
166:See also
1348:General
1255:myeloid
1217:T or NK
1188:NK cell
542:CLL/SLL
136:papular
110:papules
42:sarcoid
1192:(most
1168:HTLV-1
1060:Non-MF
949:marker
922:(most
908:T cell
580:CD11c+
498:marker
476:(most
462:B cell
402:D01931
340:
298:
252:
218:
96:, and
72:
1115:Other
985:CD30+
731:CD138
702:CD20+
596:CD79a
386:L98.8
1194:CD56
1088:CD30
1067:CD30
955:TdT+
899:T/NK
764:KSHV
740:see
727:CD38
718:PCDs
682:CD30
678:CD15
653:MALT
565:CD22
506:TdT+
483:CD20
478:CD19
397:MeSH
390:ILDS
338:ISBN
296:PMID
250:ISBN
216:ISBN
1225:EBV
1090:+:
1069:-:
959:ALL
934:CD8
929:CD4
924:CD3
819:HIV
805:HCV
776:EBV
680:+,
527:CD5
513:ALL
377:ICD
317:at
273:at
1392::
957::
945:By
733:+)
729:+/
722:PP
684:+)
674:RS
494:By
447:,
400::
384::
381:10
292:68
290:.
230:^
196:^
162:.
147:.
92:,
1291:)
1282:(
1236:)
1232:/
1228:(
1196:)
1190:/
1175:)
1171:(
1147:)
1143:(
997:)
988:(
978:)
974:(
965:)
961:(
936:)
920:)
915:,
911:(
838:)
834:(
826:)
822:(
771:)
767:(
725:(
720:/
709:)
705:(
697:)
693:(
676:(
665:)
646:(
641:/
632:)
613:(
608:/
598:+
587:)
583:(
567:+
556:)
552:(
544:)
540:(
529:+
519:)
515:(
485:)
474:)
469:,
465:(
437:e
430:t
423:v
388:(
379:-
369:D
346:.
302:.
258:.
224:.
20:)
Text is available under the Creative Commons Attribution-ShareAlike License. Additional terms may apply.
